{
    "help": "https://ckan.publishing.service.gov.uk/api/3/action/help_show?name=package_show",
    "success": true,
    "result": {
        "codelist": "",
        "contact-email": "",
        "contact-name": "",
        "contact-phone": "",
        "creator_user_id": "ed203682-6007-4e88-91c2-31003d063775",
        "foi-email": "FOI@phe.gov.uk",
        "foi-name": "",
        "foi-phone": "",
        "foi-web": "",
        "id": "bc207b50-8ead-48fb-a026-f9bec0764d1b",
        "isopen": true,
        "licence-custom": "",
        "license_id": "uk-ogl",
        "license_title": "UK Open Government Licence (OGL)",
        "license_url": "http://reference.data.gov.uk/id/open-government-licence",
        "metadata_created": "2019-07-08T14:04:06.555213",
        "metadata_modified": "2019-12-09T16:40:31.864468",
        "name": "cancer-registration-epidemiology-of-melanoma-1995-2017",
        "notes": "National Cancer Registration and Analysis Service (NCRAS). (2019). Cancer Registration: Epidemiology of Melanoma (1995-2017) [Dataset]. Public Health England. https://doi.org/10.25503/n202-3352\r\n\r\nEach row represents a C43* tumour. For each tumour the following is provided where available:\r\n\r\n\u2022\tBRESLOW, (Breslow thickness of tumour, Measured in millimetres to the nearest 0.01mm. Can be a number or range, x, or blank (e.g. \u22641mm, 1-2mm) \r\n\r\n\u2022\tdiag_quarter (diagnosis quarter is based on the calendar year) \r\n\r\n\u2022\tDIAGNOSISYEAR, (year of diagnosis, 1995-2017) \r\n\r\n\u2022\tethnicity_band (aggregated in 3 categories: 'White'; 'Non-White' and 'Unknown') \r\n\r\n\u2022\tage_group (aggregated in 3 categories: '<45'; '45-69' and '70+') \r\n\r\n\u2022\tHISTOLOGY_CODED, (histology code - combines the morphology and behaviour codes)\r\n\r\n\u2022\tHISTOLOGY_CODED_DESC, (name for the histology type) \r\n\r\n\u2022\tSEX, (coded as 1=Male and 2=Female) \r\n\r\n\u2022\tSITE_ICD10_O2, (valid 4-digit code, coded in accordance with classification system of The International Classification of Diseases for Oncology) (C430-C439) \r\n\r\n\u2022\tSITE_CODED_DESC, (Site code of the cancer, in the coding system that the tumour was originally coded in and text description) \r\n\r\n\u2022\tT_IMG, (The UICC code which classifies the size and extent of the primary tumour before treatment) \r\n\r\n\u2022\tN_IMG, (The UICC code which classifies the absence or presence and extent of regional lymph node metastases before treatment. +, 0, 1, 1a, 1b, 1c, 1mi, 2, 2a, 2b, 2c, 3, 3a, 3b, 3c, X)\r\n\r\n\u2022\tM_IMG, The UICC code which classifies the absence or presence of distant metastases pre-treatment. 0 = no distant metastasis. 1, 1a, 1b, 1c, 1e = distant metastasis. X = unknown)\r\n\r\n\u2022\tCREG_CODE, (Cancer registry catchment area code (at diagnosis) Y0201 = Northern and Yorkshire Cancer Registry and Information Service; Y0301 = Trent Cancer Registry; Y0401 = Eastern Cancer Registration and Information Centre; Y0801 = Thames Cancer Registry; Y0901 = Oxford Cancer Intelligence Unit; Y1001 = South West Cancer Intelligence Service; Y1101 = Welsh Cancer Intelligence and Surveillance Unit; Y1201 = West Midlands Cancer Intelligence Unit; Y1701 = North West Cancer Intelligence Service; Z9999 = null.\r\n\r\n\u2022\tCREG_NAME, Cancer registry catchment area name (at diagnosis) See above for coding. \r\n\r\n\u2022\tBASISOFDIAGNOSIS, Basis of diagnosis of the tumour according to all the data received by the registry. Non-microscopic: 0 = Death certificate; 1 = Clinical: Diagnosis made before death without (2-7); 2 = Clinical investigation: Includes all diagnostic techniques without a tissue diagnosis; 4 = Specific tumour markers: Includes biochemical and/or immunological markers which are site specific. \r\n\r\nMicroscopic: 5 = Cytology: Examination of cells whether from a primary or secondary site, including fluids aspirated using endoscopes or needles. Also including microscopic examination of peripheral blood films and trephine bone marrow aspirates; 6 = Histology of a metastases: Includes autopsy specimens; 7 = Histology of a primary tumour: Includes all cutting and bone marrow biopsies. Also includes autopsy specimens of a primary tumour; 9 = Unknown, e.g. PAS or HISS record only. \r\n\r\n\u2022\tMORPH_ICD10_O2, (Morphology of the cancer, in the ICD-10-O2 system)\r\n\r\n\u2022\tBEHAVIOUR_ICD10_O2 Behaviour of the cancer, in the ICD-10-O2 system\r\n\r\n\u2022\tSTAGE_BEST, (where stage 1 is coded as 1, 1A, 1A2, 1B, 1C, 1E, 1S; stage 2 is coded as 2, 2A, 2A1, 2B, 2E, 2S; stage 3 is coded as 3, 3A, 3B, 3C, 3E, 3S; stage 4 is coded as 4, 4A, 4B, 4C, 4S; unknown or cannot be stage is coded as 4, 4A, 4B, 4C, 4S; unknown or cannot be staged as 0, 6, ?, U, X, blank)\r\n\r\n\u2022\tSTAGE_PATH, (where stage 1 is coded as 1, 1A, 1B, 1E; stage 2 is coded as 2, 2A, 2B, 2E; stage 3 is coded as 3, 3A, 3B; stage 4 is coded as 4, 4A, 4B; unknown or cannot be staged as 0, 6, ?, X, blank) \r\n\r\n\u2022\tGRADE, (Grade of tumour, coded as 3, 4, G1, G2, G3, G4, G5, G6, G7, GX, Unknown or blank)\r\n\r\n\u2022\tCLARKS, (Clark's stage for skin cancer) 1 = melanoma in situ: melanoma cells are only in the epidermis; 2 = melanoma cells in the papillary dermis; 3 = melanoma cells throughout papillary dermis and touching reticula; 4 = melanoma has spread into the reticular or deep dermis; 5 = melanoma has grown into the subcutaneous fat. \r\n\r\n\u2022\tQUINTILE_2015, (Quintile score [1-5], describing income deprivation where 1= least deprived to 5= most deprived) \r\n\r\n\u2022\tDCO (Diagnosis of death certificate only coded as N=No, Y=Yes, blank)\r\n\r\n",
        "num_resources": 1,
        "num_tags": 0,
        "organization": {
            "id": "b669a115-2f1c-44e2-93cd-419999c3fbdf",
            "name": "public-health-england",
            "title": "Public Health England",
            "type": "organization",
            "description": "We work with national and local government, industry and the NHS to protect and improve the nation's health and support healthier choices. We are addressing inequalities by focusing on removing barriers to good health.\r\n\r\nPHE is an executive agency of the Department of Health",
            "image_url": "",
            "created": "2013-04-25T10:52:05.799336",
            "is_organization": true,
            "approval_status": "pending",
            "state": "active"
        },
        "owner_org": "b669a115-2f1c-44e2-93cd-419999c3fbdf",
        "private": false,
        "schema-vocabulary": "",
        "state": "active",
        "theme-primary": "health",
        "title": "Cancer Registration: Epidemiology of Melanoma (1995-2017)",
        "type": "dataset",
        "url": null,
        "version": null,
        "resources": [
            {
                "cache_last_updated": null,
                "cache_url": null,
                "created": "2019-07-08T14:07:14.835796",
                "datafile-date": "2019-07-08",
                "description": "",
                "format": ".xlsx",
                "hash": "",
                "id": "5fed8e7b-2d19-48dd-bf3f-87cf9a0311d9",
                "last_modified": null,
                "metadata_modified": "2019-07-08T14:07:14.835796",
                "mimetype": null,
                "mimetype_inner": null,
                "name": "Cancer Registration: Epidemiology of Melanoma (1995-2017)",
                "package_id": "bc207b50-8ead-48fb-a026-f9bec0764d1b",
                "position": 0,
                "resource-type": "data-link",
                "resource_type": null,
                "size": null,
                "state": "active",
                "url": "http://www.ncin.org.uk/view?rid=3995",
                "url_type": null
            }
        ],
        "tags": [],
        "groups": [],
        "relationships_as_subject": [],
        "relationships_as_object": []
    }
}